HMGB1 and infection: In the mouse keratitis model [47], as in silencing HMGB1 (siRNA use), recombinant (r) TM, composed of TM domains 1-4, (Leu 17-Ser 517), treatment led to better clinical disease scores in treated mice after after infection and slightly (1 log) lessened the plate count in cornea.